The University of Warwick Library - WebBridge

A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
Scott, R. A..  Science Translational Medicine.  v. 8. no. 341.   2016-06-01. .   

Online access not found

Sorry - based on the information provided, WebBridge cannot offer appropriate links.